New York State Common Retirement Fund’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-49
Closed -$51K 3280
2020
Q1
$51K Hold
49
﹤0.01% 2983
2019
Q4
$65K Hold
49
﹤0.01% 3095
2019
Q3
$68K Hold
49
﹤0.01% 3113
2019
Q2
$111K Buy
+49
New +$144K ﹤0.01% 3059
2017
Q2
Sell
-16
Closed -$90K 3235
2017
Q1
$90K Hold
16
﹤0.01% 2986
2016
Q4
$74K Hold
16
﹤0.01% 3012
2016
Q3
$345K Hold
16
﹤0.01% 2508
2016
Q2
$251K Buy
16
+4
+33% +$91.4K ﹤0.01% 2622
2016
Q1
$326K Sell
12
-4
-25% -$84.5K ﹤0.01% 2451
2015
Q4
$469K Sell
16
-1
-6% -$33K ﹤0.01% 2355
2015
Q3
$419K Buy
17
+10
+143% +$673K ﹤0.01% 2399
2015
Q2
$630K Buy
+7
New +$641K ﹤0.01% 2416

Other funds holding TPST

New York State Common Retirement Fund's TPST Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Tempest Therapeutics (TPST) in Q2 2020, closing a stake of 49 shares — an estimated $51K sold.

New York State Common Retirement Fund first reported a position in TPST in Q2 2015 and held it in 12 quarters. The position peaked at $630K in Q2 2015. 51 funds tracked by Wall St. Rank hold TPST as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Tempest Therapeutics position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 49 Tempest Therapeutics shares in Q2 2020, an estimated $51K.
  • New York State Common Retirement Fund first reported a position in Tempest Therapeutics in Q2 2015 and held it in 12 quarters.
  • New York State Common Retirement Fund's Tempest Therapeutics position peaked at $630K in Q2 2015.
  • 51 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.